This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West

Savings Deadline Expires:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
March 18-21, 2025
San Diego Convention CenterSan Diego, CA, USA
March 18-21, 2025
San Diego Convention Center,
San Diego, CA, USA

ACCESS TODAY'S LEADING BIOPROCESSING SCIENCE, TECHNOLOGIES AND NETWORKING OPPORTUNITIES IN A 100% DIGITAL FORMAT

Can't make it to San Diego? Don't miss out on the fun and join us virtually with the BPI US West 2025 Digital Experience Pass.


What's Included With Your Digital Experience Pass?

12 month access to recorded in-person main conference presentations

After the in-person event in San Diego concludes, get on-demand access of presentation recordings for up to a year. Please note that some speakers may request their presentations to not be recorded.

Access to the ConnectMe digital event platform starting 4 weeks before the live in-person event

Send instant message or meeting requests to both in-person and digital attendees ahead of the event!

Access to the full attendee list

Gain access to the complete list of attendees—both live and virtual. Network through video chats and easy-to-navigate meeting requests.

Access to digital exhibition and poster hall

Learn about today's novel technologies and live chat with exhibit staff and poster presenters, all from the comfort of your home!

BPI DIGITAL EXPERIENCE PASS

Our best-in-class ConnectMe digital event platform makes it easier than ever for you to access today's leading science, technologies and networking opportunities within the global bioprocessing community.

Whether you are participating as an attendee, sponsor, or speaker, our digital event platform is designed to help you accelerate promising biologics, cell & gene therapies towards commercial success.